Quantcast

Latest GlaxoSmithKline Stories

2014-07-24 12:27:40

While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., July 24, 2014 /PRNewswire/ -- Decision Resources Group finds that, for the treatment of asthma, pulmonologists in the EU5 countries (France, Germany, Italy, Spain and the United Kingdom) hold a generally positive view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid...

2014-07-23 08:30:55

LONDON, July 23, 2014 /PRNewswire/ -- Global healthcare company GSK reports Q2 results reflecting a business that is facing currency headwinds, increased price competition and supply disruptions to its Consumer business. However its CEO Sir Andrew Witty points out that the company is very much in transition, citing progress in the development pipeline as reason to be confident about long-term prospects as well as the investments being made to drive long-term growth. CFO...

2014-07-23 08:30:32

District Court Judge Orders Apotex to Immediately Recall the Authorized Generic from its Direct Customers and to Stop Selling and Supplying the Product PITTSBURGH, July 23, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining order against Apotex Inc. and Apotex Corporation in litigation relating to Paroxetine CR, the authorized generic of GlaxoSmithKline's Paxil(®)...

2014-07-17 08:28:43

PITTSBURGH, July 17, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline (GSK) in relation to Paroxetine CR, the generic version of GSK's Paxil(®) CR. GSK is now precluded from supplying product to Apotex, which marketed the product as an authorized generic. Mylan had previously been awarded damages in the amount of $106,700,000 by the District...

2014-07-08 23:08:08

Matters Involving Ongoing Litigation to Be Discussed DALLAS (PRWEB) July 08, 2014 Parties involved in lawsuits regarding the anti-psychotic drug Risperdal are scheduled to meet in the Philadelphia Court of Common Pleas to hold a conference to discuss moving litigation forward, the national law firm of Baron and Budd reports. The plaintiffs in the lawsuits accuse Janssen Pharmaceuticals, as well as parent company Johnson & Johnson, of allegedly failing to properly warn users of...

2014-07-02 08:26:15

CARLSBAD, Calif., July 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1 million payment from GlaxoSmithKline (GSK) related to the advancement of its program to develop antisense drugs to treat hepatitis B virus (HBV). http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "Our collaboration with GSK has been very productive resulting in three novel antisense drugs in our pipeline. We look forward to continuing to advance...

2014-06-27 23:07:53

GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs. Flood Law Group is investigating potential Paxil claims in light of this recent settlement. (PRWEB) June 27, 2014 GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs,...

2014-06-26 12:26:45

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlookhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/chronic_obstructive_pulmonary_disorder_copd_kol_insight_consensus_outlook.html The prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, its impact on the wider health economy is significant and there remains considerable...

2014-06-23 23:10:52

In Addition, The $105 Million Paxil Lawsuit Settlement with GlaxoSmithKline and Dozens of States, Prevents the Company From Paying Incentives to Drug Reps That Encourage Off-Label Use of Paxil and Other Medications. Columbus, OH (PRWEB) June 23, 2014 The Paxil birth defect lawyers at Wright & Schulte LLC note that GlaxoSmithKline has agreed to pay $105 million to resolve criminal and civil charges that it purportedly improperly marketed Paxil and other drugs. According to a report...

2014-06-21 12:20:21

DALLAS, June 21, 2014 /PRNewswire/ -- MarketOptimizer.org offers "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam" and "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines" market research reports in its store. The pharmaceutical market in Vietnam is set to increase at an impressive 15.4% CAGR to 2020 whereas the Philippines' pharmaceutical industry will grow at 9.4% CAGR to 2020. In Vietnam, the scarcity of...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related